XTX Topco Ltd

Position in ERAS — Erasca, Inc.

CIK 1828301 LONDON, X0

Position in ERAS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,388,459

+$2,348,291 QoQ

Shares Held

147,618

+1267.1% QoQ

Ownership

0.047%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

XTX Topco Ltd holds $287,330,176 across 373 Biotechnology names. ERAS ranks #29 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	255,431	$7,075,438
2	VRTX	Vertex Pharmaceuticals Inc / Ma	15,632	$6,980,313
3	IONS	Ionis Pharmaceuticals Inc	80,519	$6,046,171
4	EXEL	Exelixis, Inc.	134,413	$5,764,973
5	NUVL	Nuvalent, Inc.	53,354	$5,466,117
6	AGIO	Agios Pharmaceuticals, Inc.	160,880	$5,442,570
7	BMRN	Biomarin Pharmaceutical Inc	93,609	$5,287,972
8	RYTM	Rhythm Pharmaceuticals, Inc.	59,502	$5,174,888

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,388,459	147,618	+1267.1%	Shares	Defined	2026-05-15
2025-12-31	$40,168	10,798	-89.9%	Shares	Defined	2026-02-17
2025-06-30	$135,609	106,779	-13.5%	Shares	Defined	2025-08-12
2025-03-31	$169,196	123,501	+123.1%	Shares	Defined	2025-05-08
2024-12-31	$138,956	55,361	-73.4%	Shares	Defined	2025-02-13
2024-06-30	$491,880	208,424	-8.7%	Shares	Defined	2024-08-12
2024-03-31	$470,353	228,327	-2.7%	Shares	Defined	2024-05-13
2023-12-31	$499,793	234,645	+117.5%	Shares	Defined	2024-02-13
2023-09-30	$212,496	107,866	-5.8%	Shares	Defined	2023-11-13
2023-06-30	$315,989	114,489	+108.5%	Shares	Defined	2023-08-14
2023-03-31	$165,291	54,914	+46.2%	Shares	Defined	2023-05-12
2022-12-31	$161,836	37,549	+210.3%	Shares	Defined	2023-02-14
2022-09-30	$94,380	12,100	—	Shares	Defined	2022-11-14
No filing history on record for this holder in this stock.